No abstract available
MeSH terms
-
Abnormal Karyotype
-
Antigens, Neoplasm / analysis
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Asparaginase / administration & dosage
-
Biomarkers, Tumor / analysis
-
Biopsy
-
Cyclophosphamide / administration & dosage
-
DNA Nucleotidylexotransferase / analysis
-
Disease Progression
-
Doxorubicin / administration & dosage
-
Fatal Outcome
-
Female
-
Humans
-
Lymphoma, Follicular / drug therapy
-
Lymphoma, Follicular / pathology*
-
Mercaptopurine / administration & dosage
-
Methotrexate / administration & dosage
-
Middle Aged
-
Pancytopenia / etiology
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / etiology*
-
Prednisone / administration & dosage
-
Recurrence
-
Rituximab / administration & dosage
-
Salvage Therapy
-
Splenic Rupture / etiology
-
Splenomegaly / etiology
-
Stomach / pathology
-
Vincristine / administration & dosage
Substances
-
Antigens, Neoplasm
-
Biomarkers, Tumor
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Mercaptopurine
-
DNA Nucleotidylexotransferase
-
Asparaginase
-
Prednisone
-
Methotrexate
Supplementary concepts
-
CCG-141 protocol
-
CHOP protocol